|
| Essential Nutrients : Minerals | Vitamins | Carbohydrates | Proteins | Fats | Diets | Lab Test | Food | ![]() |
|
|
|
|
| Posted By : Dr.Anand Shroff, MS (OPHTH), FICS |
| Posted On : 22 Sep 2009 (Total Views : 3063) |
| Contact By Email | Contact By Phone |
Corneal collagen cross-linking with riboflavin (C3R) with Topography Guided Laser Surface Treatment (C3R + Topo guided PRK)
Corneal collagen crosslinking (C3R/ CXL) is a well-accepted and welcome addition to treatment options for keratoconus. Before C3R was approved, treatment options to rehabilitate vision were quite limited, mostly to contact lenses and when they failed one needed to undergo a penetrating keratoplasty (Corneal Transplant or Grafting).
Keratoconus is a known progressive disorder. All modalities of treatment whether it is glasses, contact lenses, INTACS or Phakic IOL's, all correct the refractive error secondary to the cone formation; they do not treat the keratoconus. Reason tells us that anything which is progressive first needs to be stopped and for that there is only one treatment that is available which is C3R or CXL.
Alternative Treatments for Keratoconus
Alternative treatments like Intacs, Rings, Semi soft or rigid lenses, are all temporary treatments. They are not very effective in controlling the condition and also lead to many other visual problems. With Intacs there are subjective complaints about vision like haloes, glare, irregular astigmatism, or monocular diplopia [double vision while seeing through one eye], which can persist. These are not compounded by C3R
Indications for C3R
Keratoconus
LASIK induced ectasia
PMCD-Pellucid Marginal Corneal Degeneration
C3R
We have over 2 years’ experience with C3R; results have been very promising with the slowing or cessation of keratoconus progression in 100% of eyes. The average amount of topographic improvement we have observed is about 2 D.
C3-riboflavin has also been shown to be effective for stabilizing keratoconus as well as most LASIK-induced ectasias
C3R + Topo guided treatment
We now perform treatments which combine C3R with an excimer laser surface treatment. We use the advanced Concerto excimer laser (WaveLight) for the topography-guided treatment.
This is only possible if the Corneal thickness is enough for both treatments and if the topography maps are found suitable for treatment.
Advantages of C3R combined with Laser Surface Treatment:
Combining C3R treatment with a topography-guided treatment leads to better visual rehabilitation and improves vision by normalizing the corneal surface and reducing irregular astigmatism. A topography-guided surface treatment is followed by C3-riboflavin.
We perform this topography-guided laser + C3R with epi-off. There is sometimes a mild initial post procedure haze, but it resolves with treatment.
This combined treatment has produced remarkable improvements in corneal Topography. The general changes produced during C3R + Topo guided PRK are flattening of the cone and improvement of the overall shape. This occurs because the combined treatment flattens the steepest area (ie, inferior) and steepens the flattest area (ie, superior).
Safety Issues
Recently, safety issues have been resolved and confirm that the endothelium, lens, and retina are not involved in any potential or real damage after the treatment.
There is some concern regarding the technique (ie, transepithelial treatment vs treatment with de-epithelization, which is doing C3R with Epithelium on or off?). We definitely advise with Epithelium off since there is no risk of damaging the retina or macula this way and a stronger cornea as the riboflavin is soaked into the cornea well.
This procedure has the necessary approval in Europe (CE) where it originated from.
What other Experts Say
“I started using this modality 4 years ago to treat post-LASIK ectasia. So far, I have treated more than 200 cases and have presented and published our results, which are encouraging. I am a strong believer in combining C3-riboflavin treatment with a conservative topography-guided treatment to better visually rehabilitate these patients. I do not wait to do this after the C3-riboflavin treatment. Instead, I perform a conservative topography-guided PRK followed by C3-riboflavin often deal with some postoperative haze, but it resolves with conservative treatment. The reward is that the refraction remains stable for years.” ~ Dr Kanellopoulos
[John Kanellopoulos, MD, is Director of Laservision Eye Institute, in Athens, Greece. He is Attending Surgeon for the Department of Ophthalmology at the Manhattan Eye, Ear, & Throat Hospital, in New York and Clinical Associate Professor of Ophthalmology at New York University Medical School].
“As an American clinician, I anxiously await US Food and Drug Administration (FDA) approval so that clinical studies may begin” ~ Dr Trokel
[Stephen L. Trokel, MD, is a Professor of Clinical Ophthalmology at Columbia University, in New York City, New York]
| Other Categories | |||
| • Allergies | • Back And Neck | • Bone And Joints | • Brain Health |
| • Cancer | • Child Health | • General | • Diet And Nutrition |
| • ENT Care | • Eye And Vision | • Kidney And Liver | • Mental Health |
| • Pregnancy | • Sexual Health | • Skin And Beauty | • Stomach Care |
| • Women Health | • Plastic Surgery | ||
| Ask a Doctor |
| Dr. Rajesh Fogla |
![]() |
| View Profile |
| Eyes Specialist |
| MBBS, DNB, FRCS, MMed (Ophth) |
![]() |
| Advertise with us, Terms and Conditions, Privacy Policy, Sitemap, Contact Us All rights reserved to www.whereincity.com | Site by : Glow Web Services Pvt. Ltd. |
|
This site does not provide medical or any other health care advice, diagnosis or treatment. The site and its services, including the information above, are for informational purposes only and are not a substitute for professional medical advice, examination, diagnosis or treatment. Always seek the advice of your physician or other qualified health professional before starting any new treatment or making any changes to existing treatment. Do not delay seeking or disregard medical advice based on information on this site. |